Clinical Trial Update: Reprab Study: PLD + Trabectedin Rechallenge [Phase 2]

View source ↗

Summary

Phase 2 trial update for PLD + Trabectedin rechallenge in relapsed ovarian cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Snippet

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Conditions: Relapsed Ovarian Cancer | Phase 2 | Status: UNKNOWN